Directly to content
  1. Publishing |
  2. Search |
  3. Browse |
  4. Recent items rss |
  5. Open Access |
  6. Jur. Issues |
  7. DeutschClear Cookie - decide language by browser settings

Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation

Kloos, Bianca ; Chakraborty, Sushmita ; Lindner, Sonja G. ; Noack, Katrin ; Harre, Ulrike ; Schett, Georg ; Krämer, Oliver H. ; Kubatzky, Katharina F.

In: Cell communication and signaling, 13 (2015), Nr. 40. pp. 1-13. ISSN 1478-811X

[img]
Preview
PDF, English
Download (2MB) | Lizenz: Creative Commons LizenzvertragPasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation by Kloos, Bianca ; Chakraborty, Sushmita ; Lindner, Sonja G. ; Noack, Katrin ; Harre, Ulrike ; Schett, Georg ; Krämer, Oliver H. ; Kubatzky, Katharina F. underlies the terms of Creative Commons Attribution 3.0 Germany

Citation of documents: Please do not cite the URL that is displayed in your browser location input, instead use the DOI, URN or the persistent URL below, as we can guarantee their long-time accessibility.

Abstract

Background: Pasteurella multocida toxin (PMT) is a potent inducer of osteoclast formation. Pigs suffering from an infection with toxigenic Pasteurella multocida strains develop atrophic rhinitis characterised by a loss of turbinate bones and conchae. However, on the molecular level the process of bone loss remains largely uncharacterised. Results: Recently it was found that PMT activates the serine/threonine kinase mammalian target of rapamycin (mTOR) in fibroblasts. Using RAW264.7 macrophages, we investigated the role of the mTOR complex 1 (mTORC1) in PMT-mediated osteoclast formation. PMT induces the differentiation of RAW264.7 macrophages into multinucleated, tartrate resistant acid phosphatase (TRAP) positive osteoclasts that are capable to resorb bone. In the presence of the mTORC1 inhibitor rapamycin, PMT was significantly less able to induce the formation of TRAP-positive osteoclasts. Accordingly, the resulting resorption of bone was strongly reduced. A major target of mTOR is the 70 kDa ribosomal protein S6 kinase 1 (p70 S6K1). Activated p70 S6K1 decreases the expression of programmed cell death protein 4 (PDCD4), a negative transcriptional regulator of osteoclastogenesis, at the protein and gene level. Ultimately this results in the activation of c-Jun, a component of the activator protein 1 (AP-1) complex, which is a major transcription factor for the induction of osteoclast-specific genes. We now demonstrate that c-Jun and its downstream target, the osteoclast-specific bone degrading protease cathepsin K, are upregulated upon PMT treatment in an mTOR-dependent manner. Conclusions: Activation of mTOR signalling plays a central role in the formation of osteoclasts through the bacterial toxin PMT. On the molecular level, PMT-induced activation of mTOR leads to down regulation of PDCD4, a known repressor of AP-1 complex, culminating in the activation of c-Jun, an essential transcription factor for triggering osteoclastogenesis.

Item Type: Article
Journal or Publication Title: Cell communication and signaling
Volume: 13
Number: 40
Publisher: Biomed Central
Place of Publication: London
Date Deposited: 30 Nov 2015 14:12
Date: 2015
ISSN: 1478-811X
Page Range: pp. 1-13
Faculties / Institutes: Medizinische Fakultät Heidelberg > Department for Infectiology
Subjects: 570 Life sciences
610 Medical sciences Medicine
About | FAQ | Contact | Imprint |
OA-LogoDINI certificate 2013Logo der Open-Archives-Initiative